Atualização de diretriz ASCO | Terapia sistêmica para câncer de mama avançado positivo para receptor do fator de crescimento epidérmico humano 2.

Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update – Journal of Clinical Oncology

Comentário no Twitter

Out on JCO the latest @ASCO Guidelines Update on the treatment of HER2-positive ABC. Key points: standard first line remains THP, new second line is T-DXd, no standard after progression to T-DXd, a setting for which we urgently need data.https://t.co/2mMxBLACmf pic.twitter.com/2sXpzqz4ym

— Paolo Tarantino (@PTarantinoMD) June 1, 2022